Search research articles
Contact Us
Filters
Showing results (251-260 of 283) with videos related to
Page
of 29
Sort By:
RMD Open
|
March 1, 2016
Predictive factors of radiological progression after 2 years of remission-steered treatment in early arthritis patients: a post hoc analysis of the IMPROVED study
Gülşah Akdemir, Marije K Verheul, Lotte Heimans, et al.
Clinical and Experimental Rheumatology
|
September 8, 2020
Mass-spectrometric identification of carbamylated proteins present in the joints of rheumatoid arthritis patients and controls
Marije K Verheul, George M C Janssen, Arnoud de Ru, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 12, 2011
Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage
Jing Shi, Rachel Knevel, Parawee Suwannalai, et al.
Annals of the Rheumatic Diseases
|
May 1, 2016
Anti-carbamylated protein antibodies: a specific hallmark for rheumatoid arthritis. Comparison to conditions known for enhanced carbamylation; renal failure, smoking and chronic inflammation
M K Verheul, S J H van Erp, D van der Woude, et al.
Frontiers in Immunology
|
May 31, 2024
Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators
Haiyu Wang, Fleur S van de Bovenkamp, Douwe J Dijkstra, et al.
Frontiers in Immunology
|
April 5, 2017
Type I Interferon Gene Response Is Increased in Early and Established Rheumatoid Arthritis and Correlates with Autoantibody Production
Julio E Castañeda-Delgado, Yadira Bastián-Hernandez, Noe Macias-Segura, et al.
PNAS Nexus
|
July 30, 2025
Modulation of immunoglobulin G oligomerization by variable domain glycans: A mechanism to regulate complement activation
Roxane Biersteker, Leoni Abendstein, Sanne van de Bovenkamp, et al.
Journal of Autoimmunity
|
June 24, 2025
Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation
M D van den Beukel, L Zhang, S van der Meulen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 4, 2023
Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation
Douwe J Dijkstra, Fleur S van de Bovenkamp, Leoni Abendstein, et al.
Annals of the Rheumatic Diseases
|
June 2, 2019
Different classes of anti-modified protein antibodies are induced on exposure to antigens expressing only one type of modification
Arieke Suzanna Berendina Kampstra, Jacqueline Stephanie Dekkers, Mikhail Volkov, et al.
Page
of 29
Search research articles
Search
Showing results (251-260 of 283) with videos related to
Sort By:
Page
of 29
RMD Open
|
March 1, 2016
Predictive factors of radiological progression after 2 years of remission-steered treatment in early arthritis patients: a post hoc analysis of the IMPROVED study
Gülşah Akdemir, Marije K Verheul, Lotte Heimans, et al.
Clinical and Experimental Rheumatology
|
September 8, 2020
Mass-spectrometric identification of carbamylated proteins present in the joints of rheumatoid arthritis patients and controls
Marije K Verheul, George M C Janssen, Arnoud de Ru, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 12, 2011
Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage
Jing Shi, Rachel Knevel, Parawee Suwannalai, et al.
Annals of the Rheumatic Diseases
|
May 1, 2016
Anti-carbamylated protein antibodies: a specific hallmark for rheumatoid arthritis. Comparison to conditions known for enhanced carbamylation; renal failure, smoking and chronic inflammation
M K Verheul, S J H van Erp, D van der Woude, et al.
Frontiers in Immunology
|
May 31, 2024
Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators
Haiyu Wang, Fleur S van de Bovenkamp, Douwe J Dijkstra, et al.
Frontiers in Immunology
|
April 5, 2017
Type I Interferon Gene Response Is Increased in Early and Established Rheumatoid Arthritis and Correlates with Autoantibody Production
Julio E Castañeda-Delgado, Yadira Bastián-Hernandez, Noe Macias-Segura, et al.
PNAS Nexus
|
July 30, 2025
Modulation of immunoglobulin G oligomerization by variable domain glycans: A mechanism to regulate complement activation
Roxane Biersteker, Leoni Abendstein, Sanne van de Bovenkamp, et al.
Journal of Autoimmunity
|
June 24, 2025
Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation
M D van den Beukel, L Zhang, S van der Meulen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 4, 2023
Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation
Douwe J Dijkstra, Fleur S van de Bovenkamp, Leoni Abendstein, et al.
Annals of the Rheumatic Diseases
|
June 2, 2019
Different classes of anti-modified protein antibodies are induced on exposure to antigens expressing only one type of modification
Arieke Suzanna Berendina Kampstra, Jacqueline Stephanie Dekkers, Mikhail Volkov, et al.
Page
of 29